Abbvie-Header Abbvie-Header

X

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

Loading...

All Data

Filters Filter refresh
×
FILTER DATA :
News Type filter
    Company filter
      Product Type filter
        Deal Size filter
          Upfront Payment filter
            refresh

            Product Type Full Screen

            Companies Full Screen

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Contact the Supplier

            Lead Product(s): PEP-010

            Therapeutic Area: Oncology Product Name: PEP-010

            Highest Development Status: IND Enabling Product Type: Peptide

            Partner/Sponsor/Collaborator: Italian Angels for Growth

            Deal Size: $3.5 million Upfront Cash: Undisclosed

            Deal Type: Series A Financing April 22, 2021

            Details:

            PEP-Therapy will use the funds to progress the clinical development of PEP-010, PEP-Therapy's lead Cell Penetrating & Interfering Peptide (CP&IP), for the treatment of advanced solid tumors.